| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afa04922d2247f6cc4458fad8791a33f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd15fea28fa5c3272dd3e41dcf3b0dd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9fcb60d4a910e62e7a006654f1586ee6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78d6e4f7cab73de0c2252d6e3ab89cf1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 |
| filingDate |
2010-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9570a093e24bfcef11a05ae70d3147f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f6447c6a2a15394a39d90fc85cac4b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddb580b9eacab958c5b0711ce2453d45 |
| publicationDate |
2010-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010095879-A2 |
| titleOfInvention |
Sirna to be bound to transcripts of apoptosis-related genes, and compositions for treating cancer using same |
| abstract |
The present invention relates to siRNA to be bound to transcripts of apoptosis-related genes, and to compositions for treating cancer using same. More particularly, the present invention relates to siRNA which is bound to the mRNA of TRAF7 (tumor necrosis factor receptor associated factor) genes or TAB2 (TAK1 binding protein 2) genes to inhibit the expression of said genes, thus leading to cancer cell-specific apoptosis and to compositions for treating cancer containing said siRNA as an active ingredient. The siRNA and the compositions containing same according to the present invention induce cancer cell-specific apoptosis, and therefore, can be used as effective anticancer therapeutic agents which cause no damage to normal cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114941010-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114941010-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114940992-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114940992-B |
| priorityDate |
2009-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |